Page 2 - Best Chordoma doctors: TOP 53 doctors

Associate Professor at the Medical University of Vienna and Deputy Head of its Clinical Division of Oncology – one of Austria's top cancer research centers.

• Over two decades specializing in medical oncology and internal medicine
• Internationally recognized for expertise in solid tumor targeted therapies
• Focuses on personalized cancer medicine and biomarker-driven treatment
• Contributes to translational research and designs new precision treatment strategies
• Senior consultant for individualized systemic cancer therapy at Wiener Privatklinik

Associate Professor Dr. Yusuf Acikgoz brings international expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in Medical Oncology with a focus on clinical trials
• Participated in Phase III studies like CheckMate-649 and Fortitude-101
• Member of American Society of Clinical Oncology (ASCO)
• Certified in Good Clinical Practice and Human Subjects Protection

Professor Keil specializes in interventional radiology, performing complex medical interventions using advanced imaging techniques at Medical Center in Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in MRI, CT, and ultrasound-guided procedures
• Former leading doctor at University Hospital of Aachen
• Chief Physician at Academic Hospital Solingen since 2022

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Nail Paksoy brings specialized expertise in oncology, with a focus on complex cases at Medipol Bahçelievler Hospital.

• Board-certified in Medical Oncology by ESMO
• Published multiple studies on rare cancers and innovative treatments
• Active participant in international clinical trials for oncology
• Associate Professor at Istanbul Medipol University

Dr. Alemdar specializes in medical oncology at Medical Park Antalya Hospital Complex, with extensive training in internal medicine and oncology.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of medical experience across various hospitals
• Specialized training at Akdeniz University Faculty of Medicine
• Works with a multidisciplinary approach for comprehensive cancer care

49 years of experience of experience specializing in virotherapy – one of the newest fields in immunology – at Pallas Clinic.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Expert in immunological treatments that can be tailored to specific conditions

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Specialized in radiation oncology with training from Marmara University, renowned for its rigorous medical program.

• Trained at Marmara University's Department of Radiation Oncology
• Completed undergraduate studies in medicine at Marmara University
• Education includes international experience from Azerbaijan

Dr. Topcu brings international expertise from MD Anderson and Sunnybrook Odette Cancer Center to Biruni University Hospital.

• Specializes in rare cancers including chordoma and sarcomas
• Member of ESMO and ASCO – global oncology standards
• Trained at top institutions in the US, Canada, and Turkey
• Works across multiple cancer types with complex cases

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Prof. Filippini specializes in surgical treatment of locally advanced tumors, with training at Memorial Sloan Kettering Cancer Center and City of Hope Oncology Center.

• Over 46 years of experience of experience in oncological surgery
• Expert in minimally invasive, laparoscopic, and robotic techniques
• Authored over 100 scientific publications and two monographs
• Professor at the University of Chieti since the 1990s

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).